Financials data is unavailable for this security.
View more
Year on year China Medical System Holdings Ltd 's revenues fell -12.43% from 9.15bn to 8.01bn. This along with an increase in selling, general and administrative costs has contributed to a reduction in net income from 3.26bn to 2.40bn, a -26.33% decrease.
| Gross margin | 74.13% |
|---|---|
| Net profit margin | 19.56% |
| Operating margin | 21.20% |
| Return on assets | 7.51% |
|---|---|
| Return on equity | 8.72% |
| Return on investment | 8.53% |
More ▼
Cash flow in CNYView more
In 2023, China Medical System Holdings Ltd did not generate a significant amount of cash. However, the company earned 2.50bn from its operations for a Cash Flow Margin of 31.23%. In addition the company used 442.28m on investing activities and also paid 2.13bn in financing cash flows.
| Cash flow per share | 0.7083 |
|---|---|
| Price/Cash flow per share | 10.52 |
| Book value per share | 7.08 |
|---|---|
| Tangible book value per share | 5.38 |
More ▼
Balance sheet in CNYView more
| Current ratio | 4.28 |
|---|---|
| Quick ratio | 3.97 |
| Total debt/total equity | 0.0717 |
|---|---|
| Total debt/total capital | 0.0667 |
More ▼
Growth rates in CNY
SmartText is unavailable
| Div yield(5 year avg) | 4.14% |
|---|---|
| Div growth rate (5 year) | 5.19% |
| Payout ratio (TTM) | 40.00% |
| EPS growth(5 years) | 5.64 |
|---|---|
| EPS (TTM) vs TTM 1 year ago | -58.73 |
More ▼
